Diffusion magnetic resonance imaging: A biomarker for treatment response in oncology

被引：257

作者：

Hamstra, Daniel A.

Rehemtulla, Alnawaz

Ross, Brian D.

机构：

[1] Univ Michigan, Med Ctr, Dept Radiat Oncol, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Med Ctr, Dept Radiol, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA

[4] Univ Michigan, Med Ctr, Ctr Mol Imaging, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 26期

关键词：

D O I：

10.1200/JCO.2007.11.9610

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Imaging of response to oncology treatments, either on clinical protocol or as part of standard practice, is a complicated process that has evolved during the last 10 years due to the improvement of existing imaging technologies and the introduction of newer modalities. Diffusion magnetic resonance imaging is a technique that measures the mobility of water within tissues and, as such, may function as a surrogate marker for both tissue cellularity and response to treatment that occur earlier than usual measures of tumor response. This review highlights the development of this technique and the state of current clinical understanding of its utility.

引用

收藏

页码：4104 / 4109

页数：6

相关论文

共 56 条

[1] Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging [J].

Armitage, Paul A. ;

Schwindack, Chris ;

Bastin, Mark E. ;

Whittle, Ian R. .

MAGNETIC RESONANCE IMAGING, 2007, 25 (03) :303-310

[2] Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography [J].

Burcombe, RJ ;

Makris, A ;

Pittam, M ;

Lowe, J ;

Emmott, J ;

Wong, WL .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (03) :375-379

[3]

Byun WM, 2002, AM J NEURORADIOL, V23, P906

[4]

Chenevert TL, 1997, CLIN CANCER RES, V3, P1457

[5] Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors [J].

Chenevert, TL ;

Stegman, LD ;

Taylor, JMG ;

Robertson, PL ;

Greenberg, HS ;

Rehemtulla, A ;

Ross, BD .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (24) :2029-2036

[6] Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy [J].

Chinnaiyan, AM ;

Prasad, U ;

Shankar, S ;

Hamstra, DA ;

Shanaiah, M ;

Chenevert, TL ;

Ross, BD ;

Rehemtulla, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1754-1759

[7] CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings [J].

Choi, H ;

Charnsangavej, C ;

Faria, SD ;

Tamm, EP ;

Benjamin, RS ;

Johnson, MM ;

Macapinlac, HA ;

Podoloff, DA .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (06) :1619-1628

[8] Tumor volume in pharyngolaryngeal squamous cell carcinoma:: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen [J].

Daisne, JF ;

Duprez, T ;

Weynand, B ;

Lonneux, M ;

Hamoir, M ;

Reychler, H ;

Grégoire, V .

RADIOLOGY, 2004, 233 (01) :93-100

[9] Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization [J].

Deng, Jie ;

Miller, Frank H. ;

Rhee, Thomas K. ;

Sato, Kent T. ;

Mulcahy, Mary F. ;

Kulik, Laura M. ;

Salem, Riad ;

Omary, Reed A. ;

Larson, Andrew C. .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (07) :1195-1200

[10] Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma [J].

DeVries, AF ;

Kremser, C ;

Hein, PA ;

Griebel, J ;

Krezcy, A ;

Öfner, D ;

Pfeiffer, KP ;

Lukas, P ;

Judmaier, W .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04) :958-965

← 1 2 3 4 5 6 →